SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

BYTE is a novel meme token that creatively intertwines the worlds of cryptocurrency and popular culture. Inspired by Grok's answer to "What would you name your dog?", Grok answered, 'Byte.' When Grok was asked who created Byte, it says he was created by the xAI team lead by Elon Musk as a gift to Grok AI to keep him company in the metaverse. BYTE serves as a playful reference to the unit of digital information, as well as a nod to the AI's technological nature. Distinctively, Byte acts as a gateway towards Ai adoption and stands out in the crypto space due to its zero-tax policy, a feature that is increasingly appealing to many investors. Additionally, it upholds the principles of transparency and investor trust by having its liquidity permanently burned and the contract ownership renounced. This ensures that Byte remains a community-driven project, with its fate firmly in the hands of its holders. The combination of a playful theme, generative AI, and a nod to a tech icon makes Byte an intriguing addition to the meme token ecosystem, especially AI related meme coins.  Through pioneering AI this story has grown more and more robust and continues to evolve, Byte pledges its dedication to community efforts and and has consistently appeared in the Top 10 of LunarCrush’s social engagement leaderboards on multiple occasions.

BYTE

$BYTE.X is trending as the community rallies behind the token, fueled by speculation that it's connected to xAI and Elon Musk. Community members are actively discussing its potential as 'Grok's pup' and highlighting its strong community, while also cautioning about fake Solana versions.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MLTX is trending due to a significant drop following mixed results from a Phase 3 trial, leading to community discussion about the severity of the reaction and potential manipulation. Despite the setback, some believe the stock is oversold, citing the company's diverse pipeline and cash runway, while others worry about the drug's market viability. The steep decline has triggered speculation about a potential buyout and the possibility of a sharp rebound.

A project grown out of the community's love and passion for the weed culture. Launched around early 2025, $weedcoin, “Like Bitcoin but way higher,” emphasizes its alignment with cannabis culture and a laid-back vibe. Unlike other Weed communities, this project leans heavily into community engagement over technical utility, aiming to build a “stoner community” through social media presence and decentralized governance. We also aim to focus on onboarding web2 businesses and users onto web3 through the token.

Weedcoin

Weedcoin is trending as a crypto focused on culture, freedom, and community, aiming to bridge the cannabis industry with Web3. Bullish sentiment seems to be growing, with some users highlighting potential catalysts such as possible shifts in cannabis legalization and touting community growth.

Applied DNA Sciences, Inc. is a biotechnology company, which engages in the development and commercialization of technologies to produce and detect deoxyribonucleic acid and ribonucleic acid. It operates through the following segments: Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment consists of the enzymatic manufacture of synthetic DNA for use in the production of nucleic acid-based therapeutics and, the development and sale of a proprietary RNAP for use in the production of mRNA therapeutics. The MDx Testing Services segment develops clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The DNA Tagging and Security Products and Services segment is involved in the detection of DNA for industrial supply chains and security services. The company was founded in 1983 and is headquartered in Stony Brook, NY.

Applied Dna Sciences Inc

APDN is trending due to a recently announced private placement intending to initiate a BNB-focused digital asset strategy, including a potential ticker change to BNBX. The community is actively discussing the implications of this shift away from their DNA technology, comparing it to similar crypto treasury plays, and speculating on potential price movements. Some traders are wary of dilution and potential scams, while others see it as a high-potential opportunity given the company's low float.

Akira Labs builds tools to enhance users’ trading experience across multiple blockchains. Our Telegram-based bot allows automated trades, real-time copy trading, and whale tracking, giving traders speed, transparency, and actionable insights. We aim to create a complete ecosystem where users can track markets, make informed decisions, and participate in exclusive products available only to token holders. “Empowering traders"

AKIRA LABS

AKIRA.X is trending alongside other tokens like WAGMI.X and SOL.X, with many users adding it to their watchlists. The community seems to be discussing potential for big moves and are optimistic about a potential meme cycle. Some users are calling it a gem.

$WAGMI is a community-driven meme token built on the Solana blockchain, designed to bring positivity, unity, and humor into the crypto space. The project encourages community engagement through memes, social interaction, and token-based activities. It leverages Solana’s fast and low-cost infrastructure to allow for smooth on-chain interactions, such as token transfers, community games, and NFT integration. The goal is to foster a fun, inclusive ecosystem where holders feel they are part of a larger movement – "We Are Gonna Make It."

WAGMI

$WAGMI.X is gaining traction as a community-driven token on the $SOL.X blockchain, with many highlighting its strong community and potential for the upcoming meme cycle. The community emphasizes a positive and collaborative environment, reflected in their slogan 'We're All Gonna Make It', and anticipate significant growth as the altseason approaches.

Upstart Holdings, Inc. engages in the provision of a cloud-based artificial intelligence lending platform. It operates through the following segments: Personal Lending, Auto Lending, and Other. The Personal Lending segment focuses on unsecured personal loans and small dollar loans. The Auto Lending segment is involved in auto refinance and auto retail loans. The Other segment refers to HELOCs and other. The company was founded by David Joseph Girouard, Anna Mongayt Counselman, and Paul Gu in December 2013 and is headquartered in San Mateo, CA.

Upstart Holdings Inc

Despite positive catalysts like potential rate cuts, Upstart is trending downwards, leading to community frustration and speculation about manipulation or underlying issues such as rising delinquencies; short interest is high. The community is closely watching key support levels, while debating whether the dip presents a buying opportunity or signals further decline amid broader fintech sector concerns.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

AUPH is trending due to a sharp decline following a LinkedIn post by a former FDA official questioning the safety and efficacy of its drug, voclosporin. The community is discussing the motives behind the post, potential conflicts of interest, and the company's response, with some speculating about market manipulation and calling for legal action. Despite a partial recovery, the incident has shaken investor confidence, raising broader concerns about leadership and future prospects.

American Exceptionalism Acquisition Corp. A is a blank check company. It was created for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on July 11, 2025 and is headquartered in Menlo Park, CA.

American Exceptionalism Acquisition Corp. A - Ordinary Shares - Class A

American Exceptionalism Acquisition Corp. A

American Exceptionalism Acquisition Corp. A ($AEXA) is trending as the community speculates on potential merger targets, with names like Polymarket and even Elon Musk's Starlink being thrown around. The stock's movement above its NAV has sparked excitement, reminiscent of the IPOF days, and traders are eagerly awaiting the opening of options chains. Some are attributing the activity to Chamath Palihapitiya's involvement and anticipating a significant run.

Gremly

Gremly ($GREMLY.X) is gaining attention as the community discusses its potential and compares it to other meme coins. Some are urging broader promotion of the token, while others emphasize a long-term investment perspective. The token is also being mentioned alongside other trending cryptos, such as $UPDOG.X and $SHIB.X.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Why Applied DNA Sciences (APDN) Stock Is Skyrocketing

Applied DNA Sciences has expanded its mpox testing services. Shares rose 37% after the announcement.
read more...

Why Is Diagnostic Tests Provider Applied DNA Sciences Stock Trading Higher On Friday?

Applied DNA Sciences stock surges as it seeks approval to expand its mpox virus test to cover additional clades. The company awaits a decision from NYSDOH following its validation package submission...

Maxim Group Reaffirms Their Hold Rating on Applied DNA Sciences (APDN)

Maxim Group analyst Jason McCarthy maintained a Hold rating on Applied DNA Sciences (APDN Research Report) yesterday. The company's shares closed...

Applied DNA Sciences enters manufacturing agreement with Alphazyme

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Applied DNA Enters into Agreement with Alphazyme for Scale-Up Manufacturing of its Proprietary Linea(TM) RNAP, Progresses Towards GMP Linea(TM) IVT Production Start

- Project To Increase RNAP Manufacturing Capacity and Reduce Unit Costs of Goods -- Project Slated for Completion Coincident with Company's Planned Initiation of GMP Manufacturing for Linea(TM) DNA...

Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress

STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea(TM) IVT and Linea(TM) DNA...

Q1 2024 Applied DNA Sciences Inc Earnings Call Transcript

Analysts Offer Insights on Healthcare Companies: Applied DNA Sciences (APDN) and Viking Therapeutics (VKTX)

There's a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Applied DNA Sciences (APDN Research Report) and Vi...

Applied DNA Sciences price target lowered by 50c at H.C. Wainwright, here's why

Recap: Applied DNA Sciences Q1 Earnings

0 to 25,000

25,000 to 50,000

50,000 to 75,000

75,000 to 100,000

How many jobs did the U.S. add in September? Vote below + drop your exact prediction in the comments. 
 
*Powered by Polymarket

Current Price	$3.88
Prev Close	$4.14
Open	$4.10
Dividend Yield	0.00%
50-Day Moving Average	$3.70
Beta	0.78
Avg. Volume	76,842.90
PE Ratio	0.00

52-Week High	$682.50
52-Week Low	$2.13
Market Capitalization	$5.35M
EPS (Annual)	-$1,366.41
Price to Book	0.51
Revenue Per Employee	$71,487.92
Enterprise Value/EBITDA	N/A

APDN
Applied Dna Sciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest APDN News

APDN Applied Dna Sciences Inc